André Tapp

1.3k total citations
29 papers, 887 citations indexed

About

André Tapp is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, André Tapp has authored 29 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in André Tapp's work include Schizophrenia research and treatment (22 papers), Treatment of Major Depression (9 papers) and Mental Health and Psychiatry (5 papers). André Tapp is often cited by papers focused on Schizophrenia research and treatment (22 papers), Treatment of Major Depression (9 papers) and Mental Health and Psychiatry (5 papers). André Tapp collaborates with scholars based in United States, United Kingdom and India. André Tapp's co-authors include A. E. Wood, Nael Kilzieh, Murray A. Raskind, M. Brincat, P. B. C. Fenwick, John Studd, Eboo Versi, Louis Appleby, Miranda Chakos and Robert A. Rosenheck and has published in prestigious journals such as The Lancet, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

André Tapp

29 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Tapp United States	13	532	153	140	134	106	29	887
Paul Mackin United Kingdom	17	637 1.2×	111 0.7×	248 1.8×	64 0.5×	43 0.4×	34	1.1k
Halldóra Jónsdóttir Norway	19	1.3k 2.4×	304 2.0×	121 0.9×	118 0.9×	217 2.0×	24	1.6k
Claudio Mencacci Italy	17	436 0.8×	259 1.7×	70 0.5×	159 1.2×	63 0.6×	74	1.0k
Thomas J. Arndt United States	8	760 1.4×	147 1.0×	71 0.5×	171 1.3×	117 1.1×	8	1.1k
P. J. Perry United States	12	526 1.0×	93 0.6×	120 0.9×	216 1.6×	64 0.6×	20	872
Stephanie Feldman United States	24	585 1.1×	178 1.2×	55 0.4×	209 1.6×	82 0.8×	48	1.2k
Haranath Parepally United States	16	986 1.9×	320 2.1×	98 0.7×	107 0.8×	204 1.9×	24	1.2k
Anne Emilie Stürup Denmark	8	577 1.1×	162 1.1×	70 0.5×	58 0.4×	139 1.3×	12	929
George A. Keepers United States	12	763 1.4×	218 1.4×	45 0.3×	106 0.8×	140 1.3×	24	1.2k
Pilar Sierra Spain	15	494 0.9×	130 0.8×	90 0.6×	115 0.9×	31 0.3×	56	783

Countries citing papers authored by André Tapp

Since Specialization

Citations

This map shows the geographic impact of André Tapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Tapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Tapp more than expected).

Fields of papers citing papers by André Tapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Tapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Tapp. The network helps show where André Tapp may publish in the future.

Co-authorship network of co-authors of André Tapp

This figure shows the co-authorship network connecting the top 25 collaborators of André Tapp. A scholar is included among the top collaborators of André Tapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Tapp. André Tapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapp, André, et al.. (2015). Quetiapine for the treatment of cocaine use disorder. Drug and Alcohol Dependence. 149. 18–24. 11 indexed citations

Dick, Malcolm, et al.. (2014). The Utility of the Dementia Severity Rating Scale in Differentiating Mild Cognitive Impairment and Alzheimer Disease From Controls. Alzheimer Disease & Associated Disorders. 29(3). 222–228. 7 indexed citations

Tapp, André, A. E. Wood, Patrick Sylvers, Nael Kilzieh, & Andrew J. Saxon. (2013). 2733 – Quetiapine for the Treatment of Cocaine Dependence. European Psychiatry. 28(S1). 1 indexed citations

Chakos, Miranda, Jayvadan K. Patel, Robert A. Rosenheck, et al.. (2011). Concomitant Psychotropic Medication Use During Treatment of Schizophrenia Patients: Longitudinal Results from the CATIE Study. Clinical Schizophrenia & Related Psychoses. 5(3). 124–134. 12 indexed citations

Tapp, André, et al.. (2011). Quetiapine for the treatment of cocaine dependence. European Psychiatry. 26(S2). 113–113. 3 indexed citations

Meredith, Charles, Craig A. Jaffe, Monique M. Cherrier, et al.. (2009). Open Trial of Injectable Risperidone for Methamphetamine Dependence. Journal of Addiction Medicine. 3(2). 55–65. 15 indexed citations

Wood, A. E., et al.. (2008). Quetiapine for the Treatment of Cocaine Dependence. Journal of Clinical Psychopharmacology. 28(2). 221–224. 24 indexed citations

Kilzieh, Nael, et al.. (2008). Time to Discontinuation and Self-Discontinuation of Olanzapine and Risperidone in Patients With Schizophrenia in a Naturalistic Outpatient Setting. Journal of Clinical Psychopharmacology. 28(1). 74–77. 19 indexed citations

Raskind, Murray A., et al.. (2006). Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats. Neuropsychopharmacology. 32(2). 284–288. 91 indexed citations

10.

Chakos, Miranda, Ira D. Glick, Alexander L. Miller, et al.. (2006). Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial. Psychiatric Services. 57(8). 1094–1101. 90 indexed citations

11.

Tapp, André, et al.. (2006). Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.. PubMed. 7(1). 1–14. 2 indexed citations

12.

Pollard, Richard, et al.. (2006). Organizational and Unit Factors Contributing to Reduction in the Use of Seclusion and Restraint Procedures on an Acute Psychiatric Inpatient Unit. Psychiatric Quarterly. 78(1). 73–81. 56 indexed citations

13.

Chakos, Miranda, Ira D. Glick, Alexander L. Miller, et al.. (2006). Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial. Psychiatric Services. 57(8). 1094–1101. 93 indexed citations

14.

Kilzieh, Nael, et al.. (2003). Depression in Kraepelinian schizophrenia. Comprehensive Psychiatry. 44(1). 1–6. 19 indexed citations

15.

Tapp, André, et al.. (2002). Combination Antipsychotic Therapy in Clinical Practice. Psychiatric Services. 54(1). 55–59. 143 indexed citations

16.

Tapp, André, et al.. (2001). Depression in patients with schizophrenia during an acute psychotic episode. Comprehensive Psychiatry. 42(4). 314–318. 39 indexed citations

17.

Healy, Daniel J., et al.. (1996). Frequency of neuropathology in a brain bank from a long-term, domiciliary population. Journal of Psychiatric Research. 30(1). 45–49. 3 indexed citations

18.

Tapp, André, et al.. (1994). Effects of brief neuroleptic discontinuation in chronic hospitalized schizophernic patients: no evidence for supersensitivity psychosis. Biological Psychiatry. 35(9). 744–744. 2 indexed citations

19.

Douglass, Alan B., et al.. (1993). Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biological Psychiatry. 34(11). 773–780. 36 indexed citations

20.

Brincat, M., André Tapp, Louis Appleby, et al.. (1987). EFFECT OF OESTROGEN AND TESTOSTERONE IMPLANTS ON PSYCHOLOGICAL DISORDERS IN THE CLIMACTERIC. The Lancet. 329(8528). 297–299. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact